MADRIGAL PHARMACEUTICALS, INC. Increase (Decrease) Due from Other Related Parties
MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Increase (Decrease) Due from Other Related Parties of -$7.33 thousand for the 9-month period ending 2016-09-30, per its 10-Q/A filed 2017-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseDueFromOtherRelatedParties · last filed 2017-03-31
- 2016-09-30: Increase (Decrease) Due from Other Related Parties 9 month -$7.33K.
- 2015-09-30: Increase (Decrease) Due from Other Related Parties 9 month -$44.49K.
| Period end | Increase (Decrease) Due from Other Related Parties 9 month |
|---|---|
| 2016-09-30 | -$7.33K 10-Q/A · filed 2017-03-31 |
| 2015-09-30 | -$44.49K 10-Q/A · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |